TrialHuman vaccines & immunotherapeutics2023

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.

Sylvie Pichon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.